Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology

Area of Science:

• Virology
• Immunology
• Animal Models

Background:

• Simian immunodeficiency virus (SIV) infection in non-human primates, particularly macaques, is a primary animal model for studying human immunodeficiency virus (HIV).
• Accurate quantification of viral RNA load is crucial for understanding HIV infection dynamics in humans and SIV in animal models.
• Existing methods may lack the sensitivity or reproducibility needed for comprehensive SIV infection studies.

Purpose of the Study:

• To develop and validate a novel isothermal amplification-based assay for quantifying SIV RNA load in macaque plasma.
• To establish a reliable method for measuring viral RNA levels in a key animal model for HIV research.
• To facilitate a deeper understanding of SIV pathogenesis, therapy, and vaccine efficacy through precise viral load measurement.

Main Methods:

• Development of a Nucleic Acid Sequence-Based Amplification (NASBA) assay for SIV RNA quantification.
• Validation of the assay's accuracy and reproducibility using model systems.
• Comparison of SIV RNA load data with other infection markers in macaques.

Main Results:

• The developed NASBA assay accurately quantifies SIV RNA load over nearly four orders of magnitude.
• The assay demonstrated high reproducibility, making it reliable for longitudinal studies.
• The method provided precise SIV RNA copy numbers in macaque plasma, enabling detailed viral load characterization.

Conclusions:

• The NASBA technology offers an accurate and reproducible method for quantifying SIV RNA load in macaque plasma.
• This assay is a valuable tool for advancing research on SIV infection and its relevance to HIV pathogenesis.
• Precise viral load measurements are essential for evaluating therapeutic interventions and vaccine strategies in the SIV macaque model.